Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Anne-Sophie Larock"'
Autor:
Anne-Laure Sennesael, Anne-Sophie Larock, Jonathan Douxfils, Laure Elens, Gabriel Stillemans, Martin Wiesen, Max Taubert, Jean-Michel Dogné, Anne Spinewine, François Mullier
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background Serious bleeding events have been frequently described in patients taking direct oral anticoagulants (DOAC). In secondary analyses of phase 3 trials, DOAC plasma concentrations were shown to correlate with bleeding outcomes. This
Externí odkaz:
https://doaj.org/article/1dc494086d60476894f7941f489d98be
Autor:
Ovidiu Vornicu, Anne-Sophie Larock, Jonathan Douxfils, François Mullier, Virginie Dubois, Jean-Michel Dogné, Maximilien Gourdin, Sarah Lessire, Anne-Sophie Dincq
Publikováno v:
European Medical Journal Hematology, Vol 4, Iss 1, Pp 78-90 (2016)
Direct oral anticoagulants (DOAC) are used in several indications for the prevention and treatment of thrombotic events. As highlighted by data from clinical trials and case studies, all DOAC carry the risk of bleeding despite careful selection and p
Externí odkaz:
https://doaj.org/article/377f3d60172e43d9aacf577e3745dcad
Autor:
Jonathan Douxfils, Sarah Lessire, François Mullier, Philippe Hainaut, Michael Hardy, Anne Spinewine, Anne-Laure Sennesael, Anne-Sophie Larock
Publikováno v:
The American journal of medicine, Vol. 134, no. 10, p. 1295-1299 (2021)
Purpose The concomitant use of direct oral anticoagulants (DOAC) and strong P-glycoprotein (P-gp) and cytochrome P450 3A4 (CYP3A4) inducers may lead to reduced DOAC levels and therapeutic failure. This study aimed to describe DOAC concentrations in p
Autor:
Justine Baudar, Maïté Guldenpfennig, Marie de Saint-Hubert, Céline Bouvy, Jonathan Douxfils, Jean-Michel Dogné, François Mullier, Célia Devroye, Sarah Lessire, Laure Morimont, Bérangère Devalet, Anne-Sophie Larock, Anne-Sophie Dincq
Publikováno v:
Journal of thrombosis and haemostasis : JTH, Vol. 17, no. 8, p. 1273-1287 (2019)
Journal of Thrombosis and Haemostasis
Douxfils, J, Morimont, L, Bouvy, C, de Saint-Hubert, M, Devalet, B, Devroye, C, Dincq, A-S, Dogné, J-M, Guldenpfennig, M, Baudar, J, Larock, A-S, Lessire, S & Mullier, F 2019, ' Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application ', Journal of thrombosis and haemostasis : JTH, vol. 17, no. 8, pp. 1273-1287 . https://doi.org/10.1111/jth.14470
Journal of Thrombosis and Haemostasis
Douxfils, J, Morimont, L, Bouvy, C, de Saint-Hubert, M, Devalet, B, Devroye, C, Dincq, A-S, Dogné, J-M, Guldenpfennig, M, Baudar, J, Larock, A-S, Lessire, S & Mullier, F 2019, ' Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application ', Journal of thrombosis and haemostasis : JTH, vol. 17, no. 8, pp. 1273-1287 . https://doi.org/10.1111/jth.14470
Background: Thrombin generation testing has been used to provide information on the coagulation phenotype of patients. The most used technique is the calibrated automated thrombogram (CAT) but it suffers from a lack of standardization, preventing its
Autor:
Franck Verschuren, Anne Spinewine, Anne-Laure Sennesael, Valérie Mathieux, Jean-Michel Dogné, Anne-Sophie Larock, Xavier Muschart, Olivia Dalleur, Bérangère Devalet
Publikováno v:
British Journal of Clinical Pharmacology. 84:1544-1556
Aims To determine the preventability of serious adverse drug reactions (ADRs) related to the use of direct oral anticoagulants (DOACs), and to explore contributing factors to preventable ADRs. Results were compared with vitamin K antagonists (VKAs).
Autor:
Noémie Despas, Hugues Jacqmin, Marc Chatelain, Jonathan Douxfils, Anne-Sophie Larock, Bernard Chatelain, François Mullier
Publikováno v:
Annales de biologie clinique. 74:637-652
Traditional anticoagulant agents such as unfractionated heparin (UFH), low molecular weight heparins (LMWHs), fondaparinux, danaparoid and bivalirudine are used in the prevention and treatment of thromboembolic diseases. However, these agents have li
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Among patients requiring an oral anticoagulant (OAC), a large proportion also take an antiplatelet agent (AP). Several studies have highlighted the significantly increased bleeding risk associated with a combined OAC (VKA mainly) and AP (a
Publikováno v:
Annales de biologie clinique. 73:745-747
Nous avons lu avec grand interet la reponse a notre article, de Janus et al. qui soulevent un point crucial, celui de l’evaluation de la fonction renale chez les patients, notamment les sujets âges, traites par anticoagulants.Dans une premiere par
Autor:
Anne-Sophie Larock, Sarah Lessire, Jonathan Douxfils, Ovidiu Ionut Vornicu, Anne-Sophie Dincq, François Mullier, Jean-Michel Dogné
Publikováno v:
Expert opinion on biological therapy. 17(10)
Idarucizumab is a specific antagonist for dabigatran etexilate (DE). The recent market authorization of idarucizumab in Europe and the USA may reassure prescribers of DE, as it can increase the safety of the emergency management of patients taking th
Autor:
Sarah Lessire, Thomas Exner, Christelle Vancraeynest, François Mullier, Bernard Chatelain, Anne-Sophie Larock, Anne-Laure Sennesael, Lionel Pochet, Jean-Michel Dogné, Jonathan Douxfils, Anne Spinewine
Publikováno v:
Thrombosis research. 157
Background The dilute Russell's viper venom time (dRVVT) has been suggested for the assessment of the intensity of anticoagulation of all direct oral anticoagulants (DOACs). This study aimed to compare the performance of an optimized liquid-stable dR